Clinical Trials on Genitourinary Cancers

Total 51508 results

Amgen

Recruiting

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion

Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers

United States
Yvan Beaussant, MD, MSci
Cy Biopharma; Pancreatic Cancer North America

Not yet recruiting

Psilocybin in Cancer Pain Study

Opioid-Related Disorders | Pain Management | Advanced Cancer | Advanced Cancers | Pain Management and Care

United States
Singapore Clinical Research Institute
ClinDatrix, Inc.; MicroVAX, LLC

Unknown

Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers (MUC-1)

Epithelial Cancers of the Lung, Breast, Ovary, Prostate and Colon

Singapore
Roger Williams Medical Center

Suspended

Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

Metastatic Cancers

United States
University of Michigan Rogel Cancer Center

Recruiting

Optimization of MRI for Radiation Therapy

Cancer Liver | Cancer Brain | Cancer Head &Neck | Cancer Pelvis

United States
Centre de recherche du Centre hospitalier universitaire...

Recruiting

68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study

Solid Cancers

Canada
Genentech, Inc.

Completed

A Study of the Safety and Pharmacokinetics of MEGF0444A Administered to Patients With Advanced Solid Tumors

Solid Cancers
M.D. Anderson Cancer Center

Completed

Perception of Palliative Care Encounter

Advanced Cancers

United States
M.D. Anderson Cancer Center

Terminated

Occupational Therapy in Palliative Care

Advanced Cancers

United States
Genentech, Inc.

Completed

A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors

Solid Cancers
Genentech, Inc.

Completed

A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Solid Cancers

United States
Genentech, Inc.

Completed

A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Study

Solid Cancers
M.D. Anderson Cancer Center
Yukiguni Maitake Company Ltd.

Terminated

Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide

Advanced Cancers

United States
Société des Produits Nestlé (SPN)

Completed

Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects

Digestive Cancers

France
Institute of Oncology Ljubljana

Recruiting

Electrochemotherapy of Gynecological Cancers (GynECT)

Gynecological Cancers

Slovenia
M.D. Anderson Cancer Center
European Commission

Completed

Rational Therapeutics Based on Matched Tumor and Normal Tissue

Advanced Cancers

United States, Spain, France, Israel
Aeglea Biotherapeutics

Completed

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors

Advanced Cancers

United States
M.D. Anderson Cancer Center
Foundation Medicine

Completed

Genomic Profiling Assay in Phase I

Advanced Cancers

United States
Hoffmann-La Roche

Completed

A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid Tumors

Solid Cancers

United States, Belgium, France, Spain
Hoffmann-La Roche

Completed

A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors

Solid Cancers

United States, Netherlands
Medical University of South Carolina

Completed

Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer

Solid Cancers

United States
Genentech, Inc.

Completed

A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor C-Met, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors

Solid Cancers
Genentech, Inc.

Completed

A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

Solid Cancers

United States
Genentech, Inc.

Completed

A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors

Solid Cancers

United States, Spain
Genentech, Inc.

Completed

A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors

Solid Cancers

United States
Genentech, Inc.

Completed

A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors

Solid Cancers

United States
Genentech, Inc.

Completed

A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors

Solid Cancers

Spain
M.D. Anderson Cancer Center

Completed

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Palliative Care and Symptom Management for the Pediatric Oncology Patient

Pediatric Cancers

United States
M.D. Anderson Cancer Center
Sabinsa Corporation

Withdrawn

Study of Curcumin, Vorinostat, and Sorafenib

Advanced Cancers
M.D. Anderson Cancer Center

Terminated

Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging

Advanced Cancers

United States
Genentech, Inc.

Completed

A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors

Solid Cancers
M.D. Anderson Cancer Center
Gilead Sciences

Recruiting

Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers

Salivary Gland Cancers | Gland

United States
Institut Claudius Regaud

Active, not recruiting

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm (COCABIO000)

Triple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mm

France
The Rogosin Institute
Vital Systems Inc.

Completed

Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared to Best Supportive Care in Colorectal Cancer Patients

Colorectal Cancers

United States
Applied Spectral Imaging Ltd.

Completed

Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test)

Bladder Cancers

United States
Hoffmann-La Roche

Terminated

Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors

Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers

Korea, Republic of, France, Spain, Belgium, United Kingdom, Singapore, Israel, Russian Federation, Taiwan, Switzerland, Turkey, United States, New Zealand, Poland, Germany
National University Hospital, Singapore

Unknown

StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients

Head and Neck Cancers | Acute Radiation Dermatitis

Singapore
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers

Advanced Cancers

China
Janssen Research & Development, LLC

Completed

A First in Man Study of MABp1 in Patients With Advanced Cancers

Advanced Cancers

United States
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Terminated

Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038)

Advanced Cancers
M.D. Anderson Cancer Center

Terminated

Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Erlotinib in Combination With Cetuximab

Advanced Cancers

United States
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer (126ASC08Q)

Advanced Solid Cancers

Korea, Republic of
Vanderbilt-Ingram Cancer Center
National Institutes of Health (NIH)

Active, not recruiting

Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents

Advanced Cancer | Relapsed Cancer | Refractory Cancer

United States
Cellworks Group Inc.

Recruiting

myCare-102: Clinical Utility and Usability of Cellworks Singula™ and Cellworks Ventura™ Reports (myCare-102)

Cancer | Relapsed Cancer | Refractory Cancer

United States
M.D. Anderson Cancer Center
American Cancer Society, Inc.

Not yet recruiting

Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis

Gastrointestinal Cancer | GI Cancers

United States
CHU de Reims

Unknown

Role of Senescence in the Development of Endometrial Cancer

Endometrial Hyperplasia and Endometrial Cancers

France
MacroGenics

Recruiting

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint Molecule

United States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Investigating the Impact of Proactive Palliative Care

Metastatic Solid Tumor Cancers | Locally Advanced Solid Tumor Cancers

United States

3

Subscribe